HAL-2/20
General Information
DRACP ID DRACP02015
Peptide Name HAL-2/20
Sequence GKWMSLWKHILK
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=30±5 µM | MTT assay | 48 h | 1 |
SW480 | Colon adenocarcinoma | Carcinoma | IC50> 40 µM | MTT assay | 48 h | 1 |
CCRF-CEM | Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia | Leukemia | Not available | MTT assay | 48 h | 1 |
Hemolytic Activity Rat erythrocytes: IC50>100 μM
Normal (non-cancerous) Cytotoxicity HUVEC: IC50=73±3 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antimicrobial; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C74H115N19O14S
Absent amino acids ACDEFNPQRTVY
Common amino acids K
Mass 172330
Pl 11.1
Basic residues 4
Acidic residues 0
Hydrophobic residues 5
Net charge 4
Boman Index -200
Hydrophobicity -32.5
Aliphatic Index 97.5
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 11000
Absorbance 280nm 1000
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22100226
Title Toxicity study of antimicrobial peptides from wild bee venom and their analogs toward mammalian normal and cancer cells
Doi 10.1016/j.peptides.2011.11.002
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available